Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

PubMed Links for HomoloGene (Select 57124)

1.

C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families.

Deltas C, Gale D, Cook T, Voskarides K, Athanasiou Y, Pierides A.

Adv Exp Med Biol. 2013;735:189-96. Review.

PMID:
23402027
2.

Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 gene.

Westra D, Vernon KA, Volokhina EB, Pickering MC, van de Kar NC, van den Heuvel LP.

J Hum Genet. 2012 Jul;57(7):459-64. doi: 10.1038/jhg.2012.57. Epub 2012 May 24.

3.

Regulating complement in the kidney: insights from CFHR5 nephropathy.

Gale DP, Pickering MC.

Dis Model Mech. 2011 Nov;4(6):721-6. doi: 10.1242/dmm.008052. Review.

4.

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis.

Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, Pusey CD, Pierides A, Kyriacou K, Athanasiou Y, Voskarides K, Deltas C, Palmer A, Frémeaux-Bacchi V, de Cordoba SR, Maxwell PH, Pickering MC.

Lancet. 2010 Sep 4;376(9743):794-801. doi: 10.1016/S0140-6736(10)60670-8. Epub 2010 Aug 25.

5.
6.

Genetic analysis of the complement factor H related 5 gene in haemolytic uraemic syndrome.

Monteferrante G, Brioschi S, Caprioli J, Pianetti G, Bettinaglio P, Bresin E, Remuzzi G, Noris M.

Mol Immunol. 2007 Mar;44(7):1704-8. Epub 2006 Sep 26.

PMID:
17000000
7.

Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.

McRae JL, Duthy TG, Griggs KM, Ormsby RJ, Cowan PJ, Cromer BA, McKinstry WJ, Parker MW, Murphy BF, Gordon DL.

J Immunol. 2005 May 15;174(10):6250-6.

8.

Location and structure of the human FHR-5 gene.

McRae JL, Murphy BE, Eyre HJ, Sutherland GR, Crawford J, Cowan PJ.

Genetica. 2002 Mar;114(2):157-61.

PMID:
12041828
9.

Factor H-related protein-5: a novel component of human glomerular immune deposits.

Murphy B, Georgiou T, Machet D, Hill P, McRae J.

Am J Kidney Dis. 2002 Jan;39(1):24-7.

PMID:
11774097
10.

Complement-regulator factor H and related proteins in otitis media with effusion.

Närkiö-Mäkelä M, Hellwage J, Tahkokallio O, Meri S.

Clin Immunol. 2001 Jul;100(1):118-26.

PMID:
11414752
11.

Complement factor H-related hybrid protein deregulates complement in dense deposit disease.

Chen Q, Wiesener M, Eberhardt HU, Hartmann A, Uzonyi B, Kirschfink M, Amann K, Buettner M, Goodship T, Hugo C, Skerka C, Zipfel PF.

J Clin Invest. 2014 Jan;124(1):145-55. doi: 10.1172/JCI71866. Epub 2013 Dec 16.

12.

Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees.

Athanasiou Y, Voskarides K, Gale DP, Damianou L, Patsias C, Zavros M, Maxwell PH, Cook HT, Demosthenous P, Hadjisavvas A, Kyriacou K, Zouvani I, Pierides A, Deltas C.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1436-46. doi: 10.2215/CJN.09541010. Epub 2011 May 12.

13.

Dense Deposit Disease/Membranoproliferative Glomerulonephritis Type II.

Cruz Corchado J, Smith RJH.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015.
2007 Jul 20 [updated 2011 May 19].

14.

Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).

Abrera-Abeleda MA, Nishimura C, Smith JL, Sethi S, McRae JL, Murphy BF, Silvestri G, Skerka C, Józsi M, Zipfel PF, Hageman GS, Smith RJ.

J Med Genet. 2006 Jul;43(7):582-9. Epub 2005 Nov 18.

15.

Human factor H-related protein 5 (FHR-5). A new complement-associated protein.

McRae JL, Cowan PJ, Power DA, Mitchelhill KI, Kemp BE, Morgan BP, Murphy BF.

J Biol Chem. 2001 Mar 2;276(9):6747-54. Epub 2000 Oct 31.

16.

Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement.

Sethi S, Fervenza FC, Zhang Y, Zand L, Meyer NC, Borsa N, Nasr SH, Smith RJ.

Kidney Int. 2013 Feb;83(2):293-9. doi: 10.1038/ki.2012.384. Epub 2012 Dec 12.

17.

The NEI/NCBI dbGAP database: genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration.

Zhang H, Morrison MA, Dewan A, Adams S, Andreoli M, Huynh N, Regan M, Brown A, Miller JW, Kim IK, Hoh J, Deangelis MM.

BMC Med Genet. 2008 Jun 9;9:51. doi: 10.1186/1471-2350-9-51.

18.

Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications.

Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH, Johnson LV, Radeke MJ, Kavanagh D, Richards A, Atkinson J, Meri S, Bergeron J, Zernant J, Merriam J, Gold B, Allikmets R, Dean M; AMD Clinical Study Group.

Ann Med. 2006;38(8):592-604.

19.

Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.

Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ.

Hum Mutat. 2010 Jun;31(6):E1445-60. doi: 10.1002/humu.21256.

PMID:
20513133
20.

Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome.

Sullivan M, Erlic Z, Hoffmann MM, Arbeiter K, Patzer L, Budde K, Hoppe B, Zeier M, Lhotta K, Rybicki LA, Bock A, Berisha G, Neumann HP.

Ann Hum Genet. 2010 Jan;74(1):17-26. doi: 10.1111/j.1469-1809.2009.00554.x.

PMID:
20059470
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk